BTYNB, an inhibitor of RNA binding protein IGF2BP1 reduces proliferation and induces differentiation of leukemic cancer cells

Leukemia is a group of diseases characterized by altered growth and differentiation of lymphoid or myeloid progenitors of blood. The existence of specific clusters of cells with stemness-like characteristics like differentiation, self-renewal, detoxification, and resistance to apoptosis in Leukemia...

Descripción completa

Detalles Bibliográficos
Autores principales: Jamal, Alam, Hassan Dalhat, Mahmood, Jahan, Sadaf, Choudhry, Hani, Imran Khan, Mohammad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9932463/
https://www.ncbi.nlm.nih.gov/pubmed/36816728
http://dx.doi.org/10.1016/j.sjbs.2023.103569

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9932463/
https://www.ncbi.nlm.nih.gov/pubmed/36816728
http://dx.doi.org/10.1016/j.sjbs.2023.103569

Ejemplares similares